Logo

American Heart Association

  2
  0


Final ID: MDP1030

Enhancing Care for Patients with ACS in Mexico: Impact of the Get With The Guidelines®-Coronary Artery Disease Mexico Project at the National Institute of Cardiology

Abstract Body (Do not enter title and authors here): Background: The GWTG initiative has improved global patient care. We introduced GWTG-CAD at Mexico’s largest referral center, the National Institute of Cardiology. This is an independent before/after quality analysis.
Hypothesis: Implementing a standardized tool will improve ACS patient management and guideline-recommended therapies.
Aims: To compare the center’s data before/after implementing the GWTG-CAD tool registry.
Methods: Retrospective, comparative study of ACS patients either transferred from eight referring hospitals or arriving directly to our center. We compared two groups: admissions from July 2022-March 2023 (before) and April 2023-April 2024 (after). Continuous variables are presented as mean±standard deviation or median and interquartile range, based on their distribution.
Data: A total of 473 patients, (202 in the before-period and 271 in the after-period). Age, gender, comorbidities and medical history were non-different between groups. The diagnoses included STEMI 73.2% vs. 58.1%, NSTEMI 23.3% vs. 38.8%, UA 3.4% vs. 2.9%. Symptom onset to first medical contact median time was 504(195-972 min) vs. 395(170-688 min), p=0.28. From the before-period, 32.2% underwent pPCI and 61.7% thrombolysis, vs. 46.2% and 42.9% in the after-period. Among all patients, the median time of arrival at referring hospital to PCI was 2,329(356-5142 min) during the before-period vs. 559(164-1702 min) in the after-period (p=0.002). Among STEMI transfers, the time of arrival at referring hospital to PCI was significantly lower (151[110-460] vs. 106[91-142] min, p=0.02). Among direct arrivals, door-to-balloon time was numerically, but not statistically lower (78.5[51-162] vs. 71[45-90] min, p=0.08). Prescription of guideline-recommended therapies from the before-period vs. after-period was DAPT (93.1% vs. 94.1%, p=0.68), ACEI/ARB (83.7% vs. 85.1%, p=0.68), BB (84.8% vs. 89.8%, p=0.10) and statins (97.3% vs. 95.3%, p=0.26). The overall survival rate was (95.5 vs. 97.4%).
Conclusions: In this comparative study we observed a significant reduction of transfer to PCI times in all ACS patients after the implementation of the GWTG-CAD project. High prescription of guideline-recommended therapies at discharge were documented.
  • Najera-rojas, Andrea  ( National Institute of Caridology , Mexico City , Mexico )
  • Arias-mendoza, Alexandra  ( National Institute of Caridology , Mexico City , Mexico )
  • Araiza, Diego  ( National Institute of Caridology , Mexico City , Mexico )
  • Robles-ledesma, Mariana  ( National Institute of Caridology , Mexico City , Mexico )
  • De Los Rios, Manuel  ( SINACOR , Culiacan , Sinaloa , Mexico )
  • Lugo Gavidia, Leslie Marisol  ( Consorcio Academico Mexicano para la obtencion de datos clinicos , Mexico City , Mexico )
  • Leiva, Jose Luis  ( Grupo Intervención San Luis , San Luis Potosi , San Luis Potosi , Mexico )
  • De Los Ríos Arce, Luis Fernando  ( National Institute of Caridology , Mexico City , Mexico )
  • Gopar-nieto, Rodrigo  ( National Institute of Caridology , Mexico City , Mexico )
  • Sierra Lara Martinez, Jorge Daniel  ( National Institute of Caridology , Mexico City , Mexico )
  • González Pacheco, Héctor  ( National Institute of Caridology , Mexico City , Mexico )
  • Author Disclosures:
    Andrea Najera-Rojas: DO NOT have relevant financial relationships | Alexandra Arias-Mendoza: No Answer | Diego Araiza: DO have relevant financial relationships ; Speaker:Boehringer Ingelheim:Active (exists now) ; Speaker:Viatris:Active (exists now) ; Speaker:Astra Zeneca:Active (exists now) ; Speaker:Novartis:Active (exists now) ; Speaker:Novo Nordisk:Active (exists now) ; Speaker:Adium:Active (exists now) | Mariana Robles-Ledesma: No Answer | Manuel De Los Rios: DO NOT have relevant financial relationships | Leslie Marisol Lugo Gavidia: No Answer | Jose Luis Leiva: No Answer | Luis Fernando De los ríos Arce: No Answer | Rodrigo Gopar-Nieto: DO NOT have relevant financial relationships | Jorge Daniel Sierra Lara Martinez: No Answer | Héctor González Pacheco: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Driving Innovation: New Approaches to Optimizing Care and Outcomes

Sunday, 11/17/2024 , 03:15PM - 04:20PM

Moderated Digital Poster Session

More abstracts on this topic:
12-lead electrocardiograms predict adverse cardiovascular outcomes of emergency department patients

Haimovich Julian, Kolossvary Marton, Alam Ridwan, Padros I Valls Raimon, Lu Michael, Aguirre Aaron

Application and Outcomes of Coronary Atherectomy in Patients with Acute Coronary Syndrome: A Report from the Nationwide J-PCI Registry

Aikawa Tadao, Minamino Tohru, Mori Yuichiro, Kohsaka Shun, Matsue Yuya, Kuno Toshiki, Yamaji Kyohei, Ozaki Dai, Tokano Takashi, Kozuma Ken

More abstracts from these authors:
PORTAL VEIN PULSATILITY INDEX, INDEPENDENT OF INFERIOR VENA CAVA DILATATION, PREDICTS ACUTE KIDNEY INJURY IN PATIENTS WITH ACUTE HEART FAILURE

Gonzalez Macedo Eder, Arias-mendoza Alexandra, Araiza Diego, Latapi Ruiz Esparza Ximena, Hernandez-pastrana Sarai, Diaz Braiana, Garcia Villarejo Mariana, Neri Bale Raul Rodrigo, Santiago Hernández Alberto, Gopar-nieto Rodrigo, Sierra Lara Martinez Jorge Daniel

Systemic Inflammation Increases 30-Day Mortality of Patients with ST-Segment Elevation Myocardial Infarction

Cuellar Jorge, Torres Ramirez Perla Lizeth, Malchan Eduardo, Araiza Diego, Sierra Lara Martinez Jorge Daniel, Briseño Jose Luis, Gopar-nieto Rodrigo, Arias Alexandra, González Pacheco Héctor

You have to be authorized to contact abstract author. Please, Login
Not Available